Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Buy
52
RMD Quote, Financials, Valuation and Earnings
Last price:
$213.68
Seasonality move
:
7.52%
Day range:
$206.74 - $214.00
52-week range:
$172.19 - $263.05
Dividend yield:
0.97%
P/E ratio:
25.26x
P/S ratio:
6.41x
P/B ratio:
5.98x
Volume:
2.3M
Avg. volume:
1.1M
1-year change:
12.92%
Market cap:
$31.4B
Revenue:
$4.7B
EPS (TTM):
$8.47
RMD Analysts' Consensus Rating
The 15 analysts providing 12-month price projections for ResMed shares anticipate an average target of $267.15, ranging from a low estimate of $195.00 to a high estimate of $295.00. This average target implies a growth of 24.85% compared to the current stock price of $213.99.
Consensus Price Target
$267.15
Highest Price Target
$295.00
Lowest Price Target
$195.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 5 | 8 | 8 |
| Hold | 6 | 6 | 6 |
| Sell | 1 | 1 | 1 |
| Consensus | Hold | Buy | Buy |
RMD Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
